In this Expert Analysis, Joel E. Gallant, MD, MPH, and Charles B. Hicks, MD, provide an in-depth discussion of the most clinically relevant new data on the management of patients with HIV infection presented at CROI 2017.
Listen to this downloadable audio from a live Webinar in which an expert faculty member discusses the clinical impact of new data reported at the Seattle meeting.
Expert faculty members Joel E. Gallant, MD, MPH, and Charles B. Hicks, MD, summarize key studies from this important annual conference.
Recent data highlighting the potential for CNS effects with newer INSTIs has given me a sense of déjà vu about how we once approached the same issue with efavirenz. Here’s my take on what we know and how to proceed.
PrEP offers an important option for curtailing HIV transmission. This review of new data from CROI emphasizes what management considerations must accompany its use.
*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.